# Assessment of Target Site Pharmacokinetics of Voriconazole in Healthy Volunteers During Sequence Therapy

> **NCT01539330** · PHASE4 · COMPLETED · sponsor: **Martin-Luther-Universität Halle-Wittenberg** · enrollment: 9 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Voriconazole
- **OTHER:** microdialysis

## Key facts

- **NCT ID:** NCT01539330
- **Lead sponsor:** Martin-Luther-Universität Halle-Wittenberg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-08
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2013-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01539330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01539330, "Assessment of Target Site Pharmacokinetics of Voriconazole in Healthy Volunteers During Sequence Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01539330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*